New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 29, 2014
11:37 EDTRPRX, FTR, OTEX, TEF, VMC, TQNT, EXAS, CVC, EWH, GALTHigh option volume stocks
High option volume stocks: RPRX EWH CVC EXAS TQNT VMC TEF OTEX FTR GALT
News For RPRX;EWH;CVC;EXAS;TQNT;VMC;TEF;OTEX;FTR;GALT From The Last 14 Days
Check below for free stories on RPRX;EWH;CVC;EXAS;TQNT;VMC;TEF;OTEX;FTR;GALT the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
September 15, 2014
08:07 EDTGALTGalectin Therapeutics issued U.S. patent for GR-MD-02
Subscribe for More Information
September 12, 2014
15:12 EDTGALTGalectin Therapeutics says in ongoing talks with large pharma companies
Subscribe for More Information
September 11, 2014
11:29 EDTFTROptions with increasing implied volatility
Options with increasing implied volatility: VNET AVNR GPRO RAX FTR JDSU PSEC APD SYY GGP
07:25 EDTGALTAegis to hold a conference
Subscribe for More Information
September 10, 2014
10:01 EDTFTRFrontier Communications CFO sees CapEx within guidance for FY
Says plans to put $3B into network over next four years. Says adding headcount for Frontier Secure over next few quarters. Comments made at the Goldman Sachs Communacopia Conference.
10:00 EDTCVCOn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:24 EDTTEFAmazon to debut Fire Phone in U.K.
Subscribe for More Information
06:04 EDTCVCCablevision initiated with a Hold at Canaccord
Target $19.
September 9, 2014
12:02 EDTFTROptions with decreasing implied volatility
Options with decreasing implied volatility: KERX CIEN FNSR PAY BKS PVH NAV BYI FTR JOY
11:34 EDTTEFVivendi considers stake in Mediaset TV unit, Bloomberg reports
Subscribe for More Information
11:22 EDTTEFVivendi considers stake in Mediaset TV unit, Bloomberg reports
Subscribe for More Information
06:03 EDTTEFTelefonica to trial AT&T's connected home technology in Europe
AT&T (T) and Telefonica (TEF) last night announced plans for a limited trial of AT&T's home security and automation service in Europe. By licensing the AT&T Digital Life platform, Telefonica can offer trial users a wireless home automation platform all managed through an easy-to-use, web-based user interface. AT&T independently owns its platform, allowing for others to license a turnkey solution. AT&T Digital Life is an IP-based, all wireless, home security, smart automation and energy management solution, all contained in an easy-to-use mobile app. Telefonica is the first company to license AT&T's Digital Life platform.
September 8, 2014
09:23 EDTOTEXOpen Text names John Doolittle as CFO
Subscribe for More Information
07:35 EDTTEFAmazon mulls Fire phone UK exclusively deal with O2, FT says
In an effort to rival Apple (AAPL) and Samsung (SSNLF) in the premium smartphone industry, Amazon (AMZN) is in final-stage discussions to sell its new Fire smartphone exclusively through Telefonica’s (TEF) O2 throughout the UK, reported the Financial Times. Reference Link
September 5, 2014
17:03 EDTTQNTTriQuint shareholders approve merger-of-equals with RF Micro Devices
Subscribe for More Information
11:47 EDTFTROptions with increasing implied volatility
Subscribe for More Information
09:13 EDTTQNTRF Micro Devices holders approve merger of equals with TriQuint
Subscribe for More Information
06:41 EDTCVCFCC head says agency to promote high speed Internet choices, NY Times reports
Stating that fewer than 25% of American homes have access to more than one high speed Internet provider, FCC Chairman Tom Wheeler said the agency would look to promote additional choices in the sector, according to The New York Times. High speed Internet providers include Comcast (CMCSA), Cablevision (CVC), Verizon (VZ), AT&T (T), and Google (GOOG). Reference Link
September 4, 2014
11:05 EDTFTROptions with increasing implied volatility
Subscribe for More Information
07:36 EDTRPRXRepros Therapeutics weakness a buying opportunity, says Brean Capital
Brean Capital said the recent weakness in Repros Therapeutics is a buying opportunity. The firm said concerns over the upcoming FDA meeting are overblown and shares were substantially oversold in response to negative commentary yesterday. Shares of Repros Therapeutics remain Buy rated with a $41 price target.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use